Red Biotechnology Market Report by Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs, and Others), Application (Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing, and Others), End User (Pharmaceutical Industry, CMO and CRO, Research Institutes, and Others), and Region 2023-2028

Red Biotechnology Market Report by Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs, and Others), Application (Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing, and Others), End User (Pharmaceutical Industry, CMO and CRO, Research Institutes, and Others), and Region 2023-2028

Report Format: PDF+Excel | Report ID: SR112023A12681
Year End sale Buy Now

Market Overview:

The global red biotechnology market size reached US$ 522.82 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 884.09 Million by 2028, exhibiting a growth rate (CAGR) of 8.62% during 2023-2028. The increasing demand for personalized medicine, extensive investments in the R&D of biotechnology products, and innovative technological advancements in genetic research represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2022
Forecast Years
2023-2028
Historical Years
2017-2022
Market Size in 2022 US$ 522.82 Million
Market Forecast in 2028 US$ 884.09 Million
Market Growth Rate (2023-2028) 8.62%


Red biotechnology refers to a branch of biotechnology that focuses on medical and pharmaceutical applications, such as developing new drugs, vaccines, and diagnostic tools. It uses gene therapy, tissue engineering, molecular diagnostics, and other biotechnologies to understand the underlying biological processes and develop new medicines to treat chronic and life-threatening diseases such as cardiovascular disorders (CVD), cancer, Alzheimer's disease, and diabetes. It conducts clinical research and trials that provide scientific analysis of the impact, risks, and benefits of the medicine. In addition to this, red biotechnology is used for engineering innovative medical devices, such as pacemakers, artificial hearts, and bionic eyes. Red biotechnology has led to significant advancements in the field of medicine, which has improved the speed and accuracy of disease diagnosis, allowing for earlier intervention, better patient outcomes, improved quality of life, and reduced healthcare costs.

Red Biotechnology Market Trends:

The rising prevalence of life-threatening diseases, such as cancer, diabetes, and cardiovascular disorders (CVD), and the growing demand for personalized medicine and therapies are primarily driving the red biotechnology market growth. In line with this, the increasing popularity of precision medicine, considerable advancements in genomics and proteomics technologies, and extensive investments in research and development (R&D) activities to develop new products and therapies are impelling the market growth. Moreover, significant improvements in stem cell research have enabled the correction of genetic composition and the development of new therapies, which, in turn, is creating a favorable outlook for the market. In addition to this, the growing use of red biotechnology for engineering novel biopharmaceuticals and artificial bones, skins, spinal discs, and cartilage is aiding in market expansion. Concurrent with this, the largescale product utilization to manufacture combined vaccines, such as diphtheria, pertussis, and tetanus (DPT) mixed with Hepatitis A, Hepatitis B, and polio vaccines, is contributing to the market growth. Furthermore, the increasing employment of bioinformatics, a combination of biology, computer science, and information technology to analyze and interpret large volumes of biological data related to genetics, genomics, and proteomics, is presenting remunerative growth opportunities for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global red biotechnology market report, along with forecasts at the global levels for 2023-2028. Our report has categorized the market based on product type, application, and end user.

Product Type Insights:

  • Diagnostic Reagents
  • Human Vaccines
  • Blood Products
  • Gene Recombinant Drugs
  • Others
     

The report has provided a detailed breakup and analysis of the red biotechnology market based on the product type. This includes diagnostic reagents, human vaccines, blood products, gene recombinant drugs, and others.

Application Insights:

  • Biopharmaceutical Production
  • Gene Therapy
  • Pharmacogenomics
  • Genetic Testing
  • Others
     

A detailed breakup and analysis of the red biotechnology market based on the application has also been provided in the report. This includes biopharmaceutical production, gene therapy, pharmacogenomics, genetic testing, and others. According to the report, biopharmaceutical production accounted for the largest market share.

End User Insights:

  • Pharmaceutical Industry
  • CMO and CRO
  • Research Institutes
  • Others
     

A detailed breakup and analysis of the red biotechnology market based on the end user has also been provided in the report. This includes pharmaceutical industry, CMO and CRO, research institutes and others. According to the report, pharmaceutical industry accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for red biotechnology. Some of the factors driving the North America red biotechnology market included the growing prevalence of chronic disorders, rising demand for personalized medicines, and ongoing advancements in gene therapy.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global red biotechnology market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Amgen Inc., AstraZeneca Plc, Biogen Inc., Bristol-Myers Squibb Company, Gilead Sciences Inc., Merck & Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Red Biotechnology Market Report Scope:

Report Features Details
Base Year of the Analysis 2022
 Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product Type
  • Application
  • End User
  • Region
Product Types Covered Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs, Others
Applications Covered Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing, Others
End Users Covered Pharmaceutical Industry, CMO and CRO, Research Institutes, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc., AstraZeneca Plc, Biogen Inc., Bristol-Myers Squibb Company, Gilead Sciences Inc., Merck & Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the global red biotechnology market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global red biotechnology market?
  • What is the impact of each driver, restraint, and opportunity on the global red biotechnology market?
  • What are the key regional markets?
  • Which countries represent the most attractive red biotechnology market?
  • What is the breakup of the market based on the ­­product type?
  • Which is the most attractive product type in the red biotechnology market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the red biotechnology market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the red biotechnology market?
  • What is the competitive structure of the global red biotechnology market?
  • Who are the key players/companies in the global red biotechnology market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the red biotechnology market from 2017-2028.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global red biotechnology market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the red biotechnology industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Red Biotechnology Market Report by Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs, and Others), Application (Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing, and Others), End User (Pharmaceutical Industry, CMO and CRO, Research Institutes, and Others), and Region 2023-2028
Purchase options Year End sale



Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More